Company Name
Boai NKY Pharmaceuticals Ltd.
Year of Establishment
1987
Enterprise Size
450 to 499
Annual Turnover(USD)
35,000,000 To 39,999,999
Company Introduction
Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) was the first company to develop and manufacture polyvinylpyrrolidone (PVP) & Copolymer of methyl vinyl ether-co-malaeic anhydride(PVM/MA)series products in China. Since 1987 NKY has dedicated in PVP production and commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP’s and the third globally. First Chinese manufacturer to be EXCiPACT GMP certified, and GMP certificate of Povidone Iodine issued by SFDA; We provide Povidone K series, Copovidone, Crospovidone, Povidone Iodine, OraRez series(PVM/MA) for oral care and surgical patches; New R&D center provides customized products, and assists our customer with formulation development; Boai NKY provides high-quality products and is more willing to be your partners; Small enough to care, Big enough to deliver! We provide below products,
PVP series: CAS NO. 9003-39-8
PVP Homopolymers(PVP K12, K15,K17,K25,K30,K90,K120 in both powder and liquid form)
VP/VA Copolymers(PVP/VA64 powder, VA64W/E/I, 73W/E/I, 37E) CAS NO.25086-89-9
Povidone Iodine CAS NO.25655-41-8
PVPP(CrospovidoneType A/Type B) CAS NO.25249-54-1
PVM/MA Copolymers (OraRez MS CAS No.62386-95-2, OraRez W-100P CAS No.25253-40-6, OraRez AN CAS No. 9001-16-9)
Intermediate Material:
Gamma Butyrolactone (GBL) CAS No.96-48-0
2-Pyrrolidone CAS NO.616-45-5
N-vinyl pyrrolidone(NVP) CAS NO. 88-12-0
N-Cyclohexyl-2-pyrrolidone CAS NO.6837-24-7
Vinylpyrrololidone (VP)/Vinylcaprolactam Copolymer (VCap) CAS No.: 51987-20-3
Vinylpyrrolidone(VP)/VinylimIdazole Copolymer (VI) CAS No. 29297-55-0
Ethyl Vinyl Ether CAS No.109-92-2
N-Vinylcaprolactam (NVCL or VCL) CAS No.2235-00-9
Tert-Butyl Vinyl Ether (TBVE) CAS No.926-02-3
Cyclohexyl Vinyl Ether CAS No.2182-55-0
N-Vinyl imidazole CAS No.1072-63-5
Main Competitive Advantages
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
Boai NKY Pharmaceuticals Ltd.
Other Competitive Advantages
professional & efficient sales team
Strong technical support and applications guidance
Patents and Copyright
having own patents
Milestone
In August of 2010, NKY was successfully to be listed on the Shenzhen Stock Exchange(ChiNext). (Stock: NKY code: 300109)